DAVID
FRAGUAS HERRÁEZ
Profesor asociado
Universitat de Barcelona
Barcelona, EspañaPublicacions en col·laboració amb investigadors/es de Universitat de Barcelona (20)
2023
-
Differences in Patterns of Stimulant Use and Their Impact on First-Episode Psychosis Incidence: An Analysis of the EUGEI Study
Schizophrenia Bulletin, Vol. 49, Núm. 5, pp. 1269-1280
-
The relationship between genetic liability, childhood maltreatment, and IQ: findings from the EU-GEI multicentric case–control study
Social Psychiatry and Psychiatric Epidemiology, Vol. 58, Núm. 10, pp. 1573-1580
2022
-
Prefrontal abnormalities, executive dysfunction and symptoms severity are modulated by COMT Val158Met polymorphism in first episode psychosis: Prefrontal abnormalities, executive dysfunction and symptoms severity
Revista de Psiquiatria y Salud Mental, Vol. 15, Núm. 2, pp. 74-87
-
The impact of cognitive reserve, cognition and clinical symptoms on psychosocial functioning in first-episode psychoses
Psychological Medicine, Vol. 52, Núm. 3, pp. 526-537
2021
-
Cognitive clusters in first-episode psychosis
Schizophrenia Research, Vol. 237, pp. 31-39
-
Fronto-parietal gray matter volume loss is associated with decreased working memory performance in adolescents with a first episode of psychosis
Journal of Clinical Medicine, Vol. 10, Núm. 17
-
Humanization in mental health plans in Spain
Revista de Psiquiatria y Salud Mental
-
The continuity of effect of schizophrenia polygenic risk score and patterns of cannabis use on transdiagnostic symptom dimensions at first-episode psychosis: findings from the EU-GEI study
Translational Psychiatry, Vol. 11, Núm. 1
-
The role of premorbid iq and age of onset as useful predictors of clinical, functional outcomes, and recovery of individuals with a first episode of psychosis
Journal of Clinical Medicine, Vol. 10, Núm. 11
-
The usefulness of Olanzapine plasma concentrations in monitoring treatment efficacy and metabolic disturbances in first-episode psychosis
Psychopharmacology, Vol. 238, Núm. 3, pp. 665-676
2020
-
Birth weight and antipsychotic induced weight gain: A prenatal programming approach in the PEPs study
Schizophrenia Research, Vol. 218, pp. 292-294
2017
-
Gene-environment interaction as a predictor of early adjustment in first episode psychosis
Schizophrenia Research, Vol. 189, pp. 196-203
2015
-
Functional deterioration from the premorbid period to 2 years after the first episode of psychosis in early-onset psychosis
European Child and Adolescent Psychiatry, Vol. 24, Núm. 12, pp. 1447-1459
2014
-
A longitudinal study on the relationship between duration of untreated psychosis and executive function in early-onset first-episode psychosis
Schizophrenia Research, Vol. 158, Núm. 1-3, pp. 126-133
-
Duration of untreated psychosis predicts functional and clinical outcome in children and adolescents with first-episode psychosis: A 2-year longitudinal study
Schizophrenia Research, Vol. 152, Núm. 1, pp. 130-138
-
Estudio farmacogenético del tratamiento a largo plazo con antipsicóticos de segunda generación y sus efectos adversos metabólicos (Estudio SLiM): justificación, objetivos, diseño y descripción de la muestra
Revista de Psiquiatria y Salud Mental, Vol. 7, Núm. 4, pp. 166-178
-
Second-generation antipsychotic use in children and adolescents: A six-month prospective cohort study in drug-naïve patients
Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 53, Núm. 11, pp. 1179-1190.e4
2012
-
Decreased glutathione levels predict loss of brain volume in children and adolescents with first-episode psychosis in a two-year longitudinal study
Schizophrenia Research, Vol. 137, Núm. 1-3, pp. 58-65
2011
-
Trait and state attributes of insight in first episodes of early-onset schizophrenia and other psychoses: A 2-year longitudinal study
Schizophrenia Bulletin, Vol. 37, Núm. 1, pp. 38-51
2009
-
Insight correlates in child- and adolescent-onset first episodes of psychosis: Results from the CAFEPS study
Psychological Medicine, Vol. 39, Núm. 9, pp. 1433-1445